Item Type | Name |
Concept
|
Adrenalectomy
|
Concept
|
Age Factors
|
Concept
|
Algorithms
|
Concept
|
Administration, Oral
|
Concept
|
Antineoplastic Agents
|
Concept
|
Antimetabolites, Antineoplastic
|
Concept
|
Chromosomes, Human, Pair 11
|
Concept
|
Antibodies, Monoclonal
|
Concept
|
Body Height
|
Concept
|
Birth Weight
|
Concept
|
Biopsy
|
Concept
|
Carcinoma, Non-Small-Cell Lung
|
Concept
|
Chromosomes, Human, Pair 1
|
Concept
|
Chicago
|
Concept
|
Glutamate-Cysteine Ligase
|
Concept
|
Contraceptive Agents, Female
|
Concept
|
Dacarbazine
|
Concept
|
DNA, Mitochondrial
|
Concept
|
Interleukin-2
|
Concept
|
Decision Support Techniques
|
Concept
|
DNA Repair
|
Concept
|
Cyclophosphamide
|
Concept
|
Chromosomes, Human, Pair 17
|
Concept
|
Etoposide
|
Concept
|
Ferritins
|
Concept
|
Microtubule-Associated Proteins
|
Concept
|
Karyotyping
|
Concept
|
Liver Neoplasms
|
Concept
|
Hydroxamic Acids
|
Concept
|
Mitotic Index
|
Concept
|
Mitosis
|
Concept
|
Immunohistochemistry
|
Concept
|
Morbidity
|
Concept
|
Cholesterol, HDL
|
Concept
|
Orbital Neoplasms
|
Concept
|
Prednisone
|
Concept
|
Gangliosides
|
Concept
|
Recurrence
|
Concept
|
Risk Factors
|
Concept
|
Cohort Studies
|
Concept
|
Japan
|
Concept
|
Incidence
|
Concept
|
Cluster Analysis
|
Concept
|
Tretinoin
|
Concept
|
Wernicke Encephalopathy
|
Concept
|
Iodine Radioisotopes
|
Concept
|
Isotretinoin
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
Concept
|
Mycobacterium avium-intracellulare Infection
|
Concept
|
Randomized Controlled Trials as Topic
|
Concept
|
Radiopharmaceuticals
|
Concept
|
Myeloablative Agonists
|
Concept
|
Hepatitis A Vaccines
|
Concept
|
Central Nervous System Neoplasms
|
Concept
|
Leukemia, Myeloid, Acute
|
Concept
|
Chi-Square Distribution
|
Concept
|
Stem Cell Transplantation
|
Concept
|
Proto-Oncogene Proteins c-myc
|
Concept
|
Case-Control Studies
|
Concept
|
Age Distribution
|
Concept
|
Ecosystem
|
Concept
|
Paraffin Embedding
|
Concept
|
Tissue Fixation
|
Concept
|
Cell Proliferation
|
Concept
|
Disease Progression
|
Concept
|
Immunomagnetic Separation
|
Concept
|
Fluorodeoxyglucose F18
|
Concept
|
Antineoplastic Agents, Alkylating
|
Concept
|
Limbic Encephalitis
|
Concept
|
Angiogenesis Inhibitors
|
Concept
|
Opsoclonus-Myoclonus Syndrome
|
Concept
|
Lymphocyte Count
|
Concept
|
Bone Marrow Neoplasms
|
Concept
|
In Situ Hybridization, Fluorescence
|
Concept
|
Fatal Outcome
|
Concept
|
Topoisomerase I Inhibitors
|
Concept
|
Hepatitis A Antibodies
|
Concept
|
Peripheral Blood Stem Cell Transplantation
|
Concept
|
B7-H1 Antigen
|
Concept
|
Hypoxia-Inducible Factor 1, alpha Subunit
|
Concept
|
Palmitic Acid
|
Concept
|
Response Elements
|
Concept
|
Parents
|
Concept
|
Lactic Acid
|
Concept
|
Loss of Heterozygosity
|
Concept
|
Gravidity
|
Concept
|
Interdisciplinary Communication
|
Concept
|
Health Status Disparities
|
Concept
|
Tetanus Toxoid
|
Concept
|
Antibodies, Monoclonal, Humanized
|
Concept
|
Human Umbilical Vein Endothelial Cells
|
Concept
|
Suspensions
|
Concept
|
Blotting, Western
|
Concept
|
HIV Infections
|
Concept
|
Hypoxia-Inducible Factor 1
|
Concept
|
Genes, myc
|
Concept
|
DNA Copy Number Variations
|
Concept
|
Drug Monitoring
|
Concept
|
Cell Hypoxia
|
Concept
|
Survival Rate
|
Concept
|
Clinical Trials, Phase III as Topic
|
Concept
|
DNA Methylation
|
Concept
|
Gene Silencing
|
Concept
|
Xenograft Model Antitumor Assays
|
Concept
|
CD4 Lymphocyte Count
|
Concept
|
Pregnancy Rate
|
Concept
|
Microsatellite Repeats
|
Concept
|
Anti-HIV Agents
|
Concept
|
Tubulin Modulators
|
Concept
|
Transcriptome
|
Concept
|
Receptors, KIR2DL1
|
Concept
|
Genome-Wide Association Study
|
Concept
|
Cytochromes c
|
Concept
|
Cell Line, Tumor
|
Concept
|
Comparative Genomic Hybridization
|
Concept
|
Intention to Treat Analysis
|
Concept
|
Epigenomics
|
Concept
|
Brain Neoplasms
|
Concept
|
Capsules
|
Concept
|
Cell Nucleolus
|
Concept
|
Clinical Trials as Topic
|
Concept
|
Disease Models, Animal
|
Concept
|
Doxorubicin
|
Concept
|
Follow-Up Studies
|
Concept
|
Longitudinal Studies
|
Concept
|
Prospective Studies
|
Concept
|
Retrospective Studies
|
Concept
|
Sex Education
|
Concept
|
Translocation, Genetic
|
Concept
|
HIV-1
|
Concept
|
Granulocyte-Macrophage Colony-Stimulating Factor
|
Concept
|
Cost of Illness
|
Concept
|
Fenretinide
|
Concept
|
Age of Onset
|
Concept
|
Computational Biology
|
Concept
|
Viral Load
|
Concept
|
Genetic Predisposition to Disease
|
Concept
|
Genomics
|
Academic Article
|
The quinoxaline anti-tumor agent (R+)XK469 inhibits neuroblastoma tumor growth.
|
Academic Article
|
Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group study.
|
Academic Article
|
Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma.
|
Academic Article
|
Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growth.
|
Academic Article
|
Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma.
|
Academic Article
|
Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma.
|
Academic Article
|
Locoregional MYCN-amplified neuroblastoma.
|
Academic Article
|
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.
|
Academic Article
|
Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project.
|
Academic Article
|
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.
|
Academic Article
|
Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group study.
|
Academic Article
|
Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee.
|
Academic Article
|
Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project.
|
Academic Article
|
Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age.
|
Academic Article
|
Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.
|
Academic Article
|
A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study.
|
Academic Article
|
Progression-free survival of two cases of high-risk neuroblastoma with refractory/relapsed disease following surgery alone.
|
Academic Article
|
Children's Oncology Group's 2013 blueprint for research: neuroblastoma.
|
Academic Article
|
Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.
|
Academic Article
|
Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group.
|
Academic Article
|
Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study.
|
Academic Article
|
Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project.
|
Academic Article
|
ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.
|
Academic Article
|
Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study.
|
Academic Article
|
Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: a report from the INRG project.
|
Academic Article
|
Two cases of localized neuroblastoma with multiple segmental chromosomal alterations and metastatic progression.
|
Academic Article
|
Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival.
|
Academic Article
|
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database.
|
Academic Article
|
Development of an open-source, flexible framework for complex inter-institutional disparate data sharing and collaboration.
|
Academic Article
|
TET1-mediated hydroxymethylation facilitates hypoxic gene induction in neuroblastoma.
|
Academic Article
|
Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project.
|
Academic Article
|
Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group project.
|
Academic Article
|
Advances in the treatment of neuroblastoma.
|
Academic Article
|
Second malignancies in patients with neuroblastoma: the effects of risk-based therapy.
|
Academic Article
|
Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group.
|
Academic Article
|
Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology Group.
|
Academic Article
|
New aspects of neuroblastoma treatment: ASPHO 2011 symposium review.
|
Academic Article
|
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial.
|
Academic Article
|
Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project.
|
Academic Article
|
Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: a report from the Children's Oncology Group (ANBL0621).
|
Academic Article
|
Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system.
|
Academic Article
|
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients.
|
Academic Article
|
Treatment of two cases with refractory, metastatic intermediate-risk neuroblastoma with isotretenoin alone or observation.
|
Academic Article
|
Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma.
|
Academic Article
|
Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma.
|
Academic Article
|
Advances in Risk Classification and Treatment Strategies for Neuroblastoma.
|
Academic Article
|
Stem Cell Transplant-Associated Wernicke Encephalopathy in a Patient with High-Risk Neuroblastoma.
|
Academic Article
|
A Selfless Act.
|
Academic Article
|
Genetic discoveries and treatment advances in neuroblastoma.
|
Academic Article
|
Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy.
|
Academic Article
|
Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence.
|
Academic Article
|
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.
|
Academic Article
|
Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database.
|
Academic Article
|
Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients.
|
Academic Article
|
Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse.
|
Academic Article
|
Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.
|
Academic Article
|
The Role of Nursing Professionals in the Management of Patients With High-Risk Neuroblastoma Receiving Dinutuximab Therapy.
|
Academic Article
|
Secreted protein acidic and rich in cysteine (SPARC) induces lipotoxicity in neuroblastoma by regulating transport of albumin complexed with fatty acids.
|
Academic Article
|
Rebound thymic hyperplasia following high dose chemotherapy and stem cell transplant in three neuroblastoma patients.
|
Academic Article
|
Data Commons to Support Pediatric Cancer Research.
|
Academic Article
|
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.
|
Academic Article
|
Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study.
|
Academic Article
|
Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma.
|
Academic Article
|
Emerging and investigational therapies for neuroblastoma.
|
Academic Article
|
Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial.
|
Academic Article
|
Immune Reconstitution Following Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma at the Time of Immunotherapy.
|
Academic Article
|
Computer-assisted Curie scoring for metaiodobenzylguanidine (MIBG) scans in patients with neuroblastoma.
|
Academic Article
|
Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531.
|
Academic Article
|
Composite tumor with pheochromocytoma and immature neuroblastoma: report of two cases with cytogenetic analysis and discussion of current terminology.
|
Academic Article
|
Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group.
|
Academic Article
|
The challenge of defining "ultra-high-risk" neuroblastoma.
|
Academic Article
|
Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma.
|
Academic Article
|
MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology group.
|
Grant
|
VARIATIONS BETWEEN RURAL AND URBAN AIDS CARE
|
Grant
|
Mechanism of SPARC peptide FSEC inhibition of angiogenesis in neuroblastoma
|
Academic Article
|
A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1.
|
Academic Article
|
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project.
|
Academic Article
|
Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System.
|
Academic Article
|
Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma.
|
Academic Article
|
Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study.
|
Academic Article
|
5-Hydroxymethylcytosine Profiles Are Prognostic of Outcome in Neuroblastoma and Reveal Transcriptional Networks That Correlate With Tumor Phenotype.
|
Academic Article
|
Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531.
|
Academic Article
|
Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial.
|
Academic Article
|
Unrealistic parental expectations for cure in poor-prognosis childhood cancer.
|
Academic Article
|
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial.
|
Academic Article
|
5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with Neuroblastoma.
|
Academic Article
|
Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project.
|
Academic Article
|
Racial and Ethnic Differences in Communication and Care for Children With Advanced Cancer.
|
Academic Article
|
The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
|
Academic Article
|
Paraneoplastic opsoclonus myoclonus syndrome associated with inflammatory myofibroblastic tumor in a pediatric patient.
|
Academic Article
|
Association between end-induction response according to the revised International Neuroblastoma Response Criteria (INRC) and outcome in high-risk neuroblastoma patients.
|
Academic Article
|
Reply to K. Beiske et al.
|
Academic Article
|
Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future.
|
Academic Article
|
A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project.
|
Academic Article
|
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032.
|
Academic Article
|
Stage 4S Neuroblastoma: Molecular, Histologic, and Immunohistochemical Characteristics and Presence of 2 Distinct Patterns of MYCN Protein Overexpression-A Report From the Children's Oncology Group.
|
Academic Article
|
Association Between Participation in Clinical Trials and Overall Survival Among Children With Intermediate- or High-risk Neuroblastoma.
|
Academic Article
|
Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastoma.
|
Academic Article
|
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium.
|
Academic Article
|
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group.
|
Academic Article
|
Pediatric Cancer Data Commons: Federating and Democratizing Data for Childhood Cancer Research.
|
Academic Article
|
Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States.
|
Academic Article
|
HIV stigma and viral load among African-American women receiving treatment for HIV.
|
Academic Article
|
Women in HIV trials: improving adherence and outcomes.
|
Academic Article
|
Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.
|
Academic Article
|
Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy.
|
Academic Article
|
Two-drug HIV regimens: more data still needed.
|
Academic Article
|
Repeat pregnancies among HIV-infected women enrolled in clinical trial PACTG1022.
|
Academic Article
|
Long-term follow-up of HIV-infected individuals who have significant increases in CD4+ cell counts during antiretroviral therapy.
|
Academic Article
|
Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion.
|
Academic Article
|
Lipids and lactate in human immunodeficiency virus-1 infected pregnancies with or without protease inhibitor-based therapy.
|
Academic Article
|
Irinotecan and temozolomide for treatment of neuroblastoma in a patient with renal failure on hemodialysis.
|
Academic Article
|
Predicting Response to Chemotherapy in Patients With Newly Diagnosed High-Risk Neuroblastoma: A Report From the International Neuroblastoma Risk Group.
|
Academic Article
|
Rethinking high-risk neuroblastoma treatment.
|
Academic Article
|
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.
|
Academic Article
|
Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group.
|
Academic Article
|
MYCN and HIF-1 directly regulate TET1 expression to control 5-hmC gains and enhance neuroblastoma cell migration in hypoxia.
|
Academic Article
|
A Community Call to Action to Prioritize Inclusion and Enrollment of Women in HIV Cure-related Research.
|
Academic Article
|
The Experience of Children With Neuroblastoma and Their Parents During Single-Room Isolation for 131I-Metaiodobenzylguanidine Therapy: A Qualitative Descriptive Study.
|
Academic Article
|
Long-Term Morbidity and Mortality Among Survivors of Neuroblastoma Diagnosed During Infancy: A Report From the Childhood Cancer Survivor Study.
|
Academic Article
|
Multimodality treatment for recurrent neuroblastoma in the central nervous system.
|
Concept
|
Rituximab
|
Concept
|
Filgrastim
|
Concept
|
N-Myc Proto-Oncogene Protein
|
Concept
|
Antineoplastic Agents, Immunological
|
Academic Article
|
Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification.
|
Academic Article
|
T-cell inflammation is prognostic of survival in patients with high-risk neuroblastoma enriched for an adrenergic signature.
|
Academic Article
|
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
|
Academic Article
|
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
|
Academic Article
|
In Memoriam: Sharon B. Murphy, MD (1943-2023).
|
Academic Article
|
Factors influencing parents' choice of palliative treatment goals for children with relapsed or refractory neuroblastoma: A multi-site longitudinal survey study.
|
Academic Article
|
Persistence of Racial and Ethnic Disparities in Risk and Survival for Patients with Neuroblastoma over Two Decades.
|
Academic Article
|
Impact of Risk-Based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the childhood cancer survivor study.
|